zona pellucida glycoproteins

major glycoproteins of zona; sperm receptor; 3 major classes of ZP are ZPA (ZP2), ZPB (ZP3alpha), and ZPC (ZP3); separate record for ZP3alpha/ZPB protein
Also Known As:
ZP1 protein, human; ZP2 protein, human; ZP2 protein, zebrafish; ZP3 protein, human; ZPB protein, mouse; ZPC protein, human; Zp-2 protein, mouse; Zp-3 protein, mouse; Zp1 protein, mouse; Zp2 protein, mouse; Zp3 protein, mouse; Zp4 protein, rat; zona pellucida 4, rat; zona pellucida B glycoprotein, rat; zona pellucida glycoprotein 1 (sperm receptor), human; zona pellucida glycoprotein 1, mouse; zona pellucida glycoprotein 2 (sperm receptor), human; zona pellucida glycoprotein 2, mouse; zona pellucida glycoprotein 3 (sperm receptor), human; zona pellucida glycoprotein 3, mouse; zona pellucida glycoprotein A, human; zona pellucida glycoprotein C, human
Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results


1. Chaudhary, Manjari: 1 article (07/2008)
2. Van Meter, Stuart E: 1 article (07/2008)
3. Upadhyaya, Nirmala B: 1 article (07/2008)
4. White, Rachel S: 1 article (07/2008)
5. Bansal, Pankaj: 1 article (07/2008)
6. Gupta, Satish K: 1 article (07/2008)
7. Svetlikova, Marta: 1 article (07/2008)
8. Bukovsky, Antonin: 1 article (07/2008)
9. Copas, Pleas: 1 article (07/2008)
10. Chakravarty, Sanchita: 1 article (07/2008)

Related Diseases

1. Herpes Zoster
2. Dysmenorrhea (Menstrual Pain)
01/01/1995 - " Contraception for women comprises the following: 1) agents that prevent ovulation; prolonged breast feeding (98% safe contraception within the first 6 months); oral contraceptives containing estrogens and gestagens (60-80 million women use them worldwide; in 1968 the 50 g estrogen containing pill, in 1972 the micropill with 30 g of ethinyl estradiol [EE], and in 1992 the ultra-low-dose pill with 20 g of EE were introduced); and future developments (third generation progestagens, antigestagens, nonsteroidal natural substances, melatonin, the combination of gonadotropin-releasing hormone analogs and natural estrogens); 2) prevention of fertilization: mechanical methods (diaphragm, sterilization methods by laparoscopy or chemical means); chemical methods (spermicides such as nonoxynol); behavioral methods (temperature methods using refined measurement of the body temperature, cervical mucus resistance); hormonal methods (implants such as Norplant containing levonorgestrel [LNG], Implanon containing 3-ketodesogestrel, the vaginal ring [the WHO-ring and the Organon ring], the minipill with pure gestagen, one-month injection with Cyclofem), IUDs (copper-containing IUDs, LNG-containing IUDs with a Pearl Index of 0.2-0.5 and reduction of dysmenorrhea); and immunological contraception (ovum and spermatozoon antigens); 3) the prevention of implantation: hormonal methods (the morning-after pill with high-dose EE or the combination of estrogen and gestagen); insertion of an IUD up to the 6th day after coitus; immunological methods (human chorionic gonadotropin antibodies, antibodies against the zona pellucida glycoproteins, implantation inhibition through interaction with interleukin IL-1 receptor, and antibodies against specific proteins of the endometrium influencing implantation). "

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Nonoxynol (Nonoxynol 9)
3. Levonorgestrel (Plan B)
4. Progestins (Progestagens)
5. Melatonin
6. Gonadotropin-Releasing Hormone (GnRH)
7. Interleukins
8. Chorionic Gonadotropin (Human Chorionic Gonadotropin)
9. Ethinyl Estradiol (Estinyl)
10. Estrogens (Estrogen)

Related Therapies and Procedures

1. Female Contraceptive Devices (Vaginal Ring)
2. Immunologic Contraception (Immunocontraception)
3. Contraception (Birth Control)